Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Journal of Pathology ; (12): 160-165, 2017.
Article in Chinese | WPRIM | ID: wpr-808352

ABSTRACT

Objective@#To study the expression of microRNA-221(miR-221) and IL-17 in papillary thyroid carcinoma (PTC) and their roles in the carcinogenesis of PTC.@*Methods@#Real-time RT-PCR, Western blot and immunohistochemistry (IHC) were used to detect the expression of miR-221 and IL-17 in 40 cases of PTC, 20 adjacent normal thyroid tissues and 20 cases of nodular goiter, and the correlation with clinicopathologic features was analyzed.@*Results@#(1)The expression level of miR-221 was significantly higher in PTC compared with nodular goiter and adjacent normal thyroid tissue (P<0.05), but not between the latter two (P>0.05). The expression of miR-221 was related to TNM staging, capsular invasion and lymph node metastasis (P<0.05) but not to patients′ age, sex, tumor size, multifocality, tumor spread and vascular invasion.(2)Real-time RT-PCR and Western blot showed that higher levels of IL-17 mRNA and IL-17 protein in PTC than nodular goiter and adjacent normal thyroid tissue (P<0.05), but not between the latter two (P>0.05). IHC assay showed positive expression of IL-17 in PTC but not in nodular goiter and adjacent normal thyroid tissue. IL-17 expression was related to TNM staging, capsular invasion and lymph node metastasis, but not to patients′ age, sex, tumor size, tumor spread and vascular invasion.(3) Expression analysis revealed a significant correlation between the miR-221 and IL-17 expression (r=0.524, P=0.001).@*Conclusions@#The expressions of miR-221 and IL-17 are significantly higher and positively correlated in PTC, suggesting that miR-221 may regulate IL-17 expression by interacting with a variety of cytokines and inflammatory cells to participate in the development of PTC. miR-221 may be a potential novel prognostic indicator and therapeutic target for PTC.

2.
Chinese Journal of Ultrasonography ; (12): 240-243, 2012.
Article in Chinese | WPRIM | ID: wpr-425092

ABSTRACT

Objective To investigate the differential value of contrast-enhanced ultrasonography (CEUS) and time-intensity curves(TIC) in diagnosing testicular and epididymal mass lesions.Methods CEUS via intravenous bolus injection of SonoVue and TIC were performed for quantitative analysis of testicular and epididymal mass lesions.Forty-one patients with 42 testicular and epididymal mass lesions and 26 normal testicles were examined with CUES,the perfusion progress were recorded dynamically,which findings were compared with surgery.Results Twenty-three (54.76%) malignant masses displayed enhanced pattern as evenly enhanced,fast-in and fast-out (8.7%),evenly enhanced,fast-in and slow-out (65.2 % ),unevenly enhanced,fast-in and slow-out (26.1% ).Ninteen (45.24 % ) benign masses revealed enhanced pattern as unevenly enhanced,fast-in and slow-out ( 10.5 %),evenly enhanced,slow-in and slowout ( 10.5 % ),unevenly enhanced,slow-in and slow-out ( 36.9 % ),without enhancement ( 42.1% ).There was statistical difference of peak intensity,time to peak and areas among malignant group,benign group and normal group ( P < 0.05).Conclusions CEUS combined with TIC could provide differential diagnostic value for testicular and epididymal mass lesions.

SELECTION OF CITATIONS
SEARCH DETAIL